Home » Headlines » Currently Reading:

Morning Headlines 1/17/17

January 16, 2017 Headlines 1 Comment

Trump Is Considering Another Thiel Associate to Lead FDA

President-elect Trump is reportedly considering Silicon Valley executive Balaji Srinivasan to lead the FDA. Srinivasan has no medical background, but earned consideration because he is a Peter Thiel associate.

Survey Snapshot: What Patient Engagement Technology Is Good For

A recent NEJM Catalyst survey on patient engagement tools finds that providers are excited about the potential benefits associated with new technologies, but do not know which ones to recommend.

You can now book workout classes directly from Google

Google partners with digital health startup MindBody to let users search for, book, and pay for exercises and wellness classes from within Google’s search results.

Why Regulating AI Is A Mistake

Following the recent death of a passenger who was driving in an auto-piloted Tesla, AI experts weigh in on the pros and cons of regulating the use of artificial intelligence.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there is "1 comment" on this Article:

  1. Thiel, who injects himself with the blood of youngsters and thinks women should not have been given the right to vote, strikes again. “O’Neill, the first FDA candidate pushed by Thiel, proved controversial because of earlier comments suggesting that the FDA approve drugs based on safety data alone and let the market decide if they were effective.” The Market, of course, being human bodes that will be harmed or destroyed by ineffective medication. My god.

    I’m increasingly of the opinion that any STEM major must have as graduation requirements courses in History, Philosophy, and Literature. The human narrative, indeed, *humanity* is completely absent from these people worshipping at the altar of “disruption”. If you don’t care about people, go make video games or rockets to Mars or something; please, please get far away from anything that has to do with medicine.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links